Video

Pfizer CentreOne Capacity Update October 2023: Small Molecule

Source: Pfizer CentreOne Oral Solids

In this session from the October 2023 Outsourced Pharma Capacity Update, Senior Business Development Manager, Liam Heath, highlights Pfizer CentreOne’s overall small molecule capabilities, with a focus on their ability to help meet your complex Oral Solid Dose needs. From pellets, tablets and capsules to innovative release profiles, Pfizer CentreOne has the global expertise to help meet your needs across a wide range of platforms and technologies.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Pfizer CentreOne Oral Solids